Bridgeway Capital Management’s VivoSim Labs VIVS Stock Holding History

Bridgeway Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-540	Closed	-$46K	–	1367
2019 Q4	$46K	Sell	540 -913	-63%	-$85.5K	﹤0.01%	1280
2019 Q3	$91K	Hold	1,453	–	–	﹤0.01%	1250
2019 Q2	$182K	Sell	1,453 -416	-22%	-$78.6K	﹤0.01%	1193
2019 Q1	$445K	Hold	1,869	–	–	0.01%	1054
2018 Q4	$429K	Buy	1,869 +729	+64%	+$184K	0.01%	1044
2018 Q3	$315K	Hold	1,140	–	–	﹤0.01%	1243
2018 Q2	$383K	Sell	1,140 -683	-37%	-$225K	﹤0.01%	1202
2018 Q1	$451K	Buy	1,823 +1,140	+167%	+$333K	﹤0.01%	1123
2017 Q4	$220K	Buy	683 +43	+7%	+$16K	﹤0.01%	1267
2017 Q3	$341K	Buy	+640	New	+$341K	﹤0.01%	1179

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

Bridgeway Capital Management's VIVS Position: Q1 2020 in Review

Bridgeway Capital Management sold out of VivoSim Labs (VIVS) in Q1 2020, closing a stake of 540 shares — an estimated $46K sold.

Bridgeway Capital Management first reported a position in VIVS in Q3 2017 and held it in 10 quarters. The position peaked at $451K in Q1 2018. 75 funds tracked by Wall St. Rank hold VIVS as of Q1 2020.

Bridgeway Capital Management reported no remaining VivoSim Labs position as of Q1 2020 after selling out during the quarter.
Bridgeway Capital Management sold 540 VivoSim Labs shares in Q1 2020, an estimated $46K.
Bridgeway Capital Management first reported a position in VivoSim Labs in Q3 2017 and held it in 10 quarters.
Bridgeway Capital Management's VivoSim Labs position peaked at $451K in Q1 2018.
75 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2020.

Based on Bridgeway Capital Management's 13F filing for Q1 2020, filed 15 May 2020.